Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

NOTIFICATION OF CHANGE IN SHAREHOLDING


Posted on: 11 Sep 18

11 September 2018

Certain information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 (“MAR”). Upon publication of this Announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain. The Company confirms that it currently has no unpublished price sensitive information.

EASTPHARMA LTD
("the Company")

NOTIFICATION OF CHANGE IN SHAREHOLDING

In conformity with the disclosure and transparency rules of the United Kingdom Listing Authority (“UKLA”) (“DTR”) and MAR, the Company hereby notifies the market of the following:

The Company received notice that on 6 September 2018, Investimentos Corp acquired 5,524,283 ordinary shares in the capital of the Company from D.E. Shaw Laminar Portfolios, L.L.C. (“DE Shaw”) (representing 8.2% of the issued share capital of the Company) (the “Acquisition”).

Investimentos Corp is an investment company incorporated in the Bahamas, established by Mr. Philipp Haas (the Chairman and CEO of the Company).

Following the Acquisition, Mr. Haas holds 0.9% of the issued share capital of the Company and subject to trustee discretion may beneficially hold a further interest of up to 8.2 % of the issued share capital of the Company.

The Company

EastPharma Ltd - a company active in the manufacturing and marketing of pharmaceutical products in Turkey and in other regional markets; for further information please visit www.eastpharma.com.

THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS ANNOUNCEMENT IN JURISDICTIONS OTHER THAN THE UNITED KINGDOM MAY BE RESTRICTED BY LAW AND THEREFORE ANY PERSONS WHO ARE SUBJECT TO THE LAWS OF ANY JURISDICTION OTHER THAN THE UNITED KINGDOM SHOULD INFORM THEMSELVES ABOUT, AND OBSERVE, ANY APPLICABLE REQUIREMENTS. THIS ANNOUNCEMENT HAS BEEN PREPARED FOR THE PURPOSES OF COMPLYING WITH ENGLISH LAW AND THE INFORMATION DISCLOSED MAY NOT BE THE SAME AS THAT WHICH WOULD HAVE BEEN DISCLOSED IF THIS ANNOUNCEMENT HAD BEEN PREPARED IN ACCORDANCE WITH THE LAWS AND REGULATIONS OF ANY JURISDICTION OUTSIDE OF ENGLAND.

GlobeNewswire
globenewswire.com

Last updated on: 12/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.